Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comparative pathology of human and canine myxomatous mitral valve degeneration: 5HT and TGF-β mechanisms
Mark A. Oyama, Chad Elliott, Kerry A. Loughran, et al.
Cardiovascular Pathology (2020) Vol. 46, pp. 107196-107196
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Genetics and pathophysiology of mitral valve prolapse
Constance Delwarde, Romain Capoulade, Jean Mérot, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 25
Autophagy regulates cellular senescence by mediating the degradation of CDKN1A/p21 and CDKN2A/p16 through SQSTM1/p62-mediated selective autophagy in myxomatous mitral valve degeneration.
Qiyu Tang, Keyi Tang, Greg Markby, et al.
Autophagy (2025)
Open Access | Times Cited: 1
TGF‐β‐induced PI3K/AKT/mTOR pathway controls myofibroblast differentiation and secretory phenotype of valvular interstitial cells through the modulation of cellular senescence in a naturally occurring in vitro canine model of myxomatous mitral valve disease
Qiyu Tang, Greg Markby, Andrew J. MacNair, et al.
Cell Proliferation (2023) Vol. 56, Iss. 6
Open Access | Times Cited: 21
Gut Dysbiosis and Its Associations with Gut Microbiota-Derived Metabolites in Dogs with Myxomatous Mitral Valve Disease
Qinghong Li, Éva Larouche‐Lebel, Kerry A. Loughran, et al.
mSystems (2021) Vol. 6, Iss. 2
Open Access | Times Cited: 38
Metabolomics Analysis Reveals Deranged Energy Metabolism and Amino Acid Metabolic Reprogramming in Dogs With Myxomatous Mitral Valve Disease
Qinghong Li, Éva Larouche‐Lebel, Kerry A. Loughran, et al.
Journal of the American Heart Association (2021) Vol. 10, Iss. 9
Open Access | Times Cited: 29
Involvement of TGF-β, mTOR, and inflammatory mediators in aging alterations during myxomatous mitral valve disease in a canine model
Arkadiusz Grzeczka, Szymon Graczyk, Paweł Kordowitzki
GeroScience (2025)
Closed Access
Whole exome sequencing of 80 cases of sporadic mitral valve prolapse reveals novel disease-associated genes and variants in a Southern Chinese population
Qiuji Wang, Junfei Zhao, Huanlei Huang
Genes & Genomics (2025)
Closed Access
Mitral Valve Prolapse and Its Motley Crew‐Syndromic Prevalence, Pathophysiology, and Progression of a Common Heart Condition
Jordan Morningstar, Annah Nieman, Christina Wang, et al.
Journal of the American Heart Association (2021) Vol. 10, Iss. 13
Open Access | Times Cited: 25
The modified outer membrane protein Amuc_1100 of Akkermansia muciniphila improves chronic stress-induced anxiety and depression-like behavior in mice
Rongrong Cheng, Haiyan Zhu, Sun Yan, et al.
Food & Function (2022) Vol. 13, Iss. 20, pp. 10748-10758
Closed Access | Times Cited: 16
Serum Proteomic Profiles Reflect the Stages of Myxomatous Mitral Valve Disease in Dogs
Dina Rešetar Maslov, Vladimir Farkaš, Ivana Rubić, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7142-7142
Open Access | Times Cited: 9
Evaluation of stem-cell therapies in companion animal disease models: a concise review (2015-2023)
Zoë J. Williams, Lynn M. Pezzanite, Lyndah Chow, et al.
Stem Cells (2024) Vol. 42, Iss. 8, pp. 677-705
Closed Access | Times Cited: 3
Monoamine Oxidase Contributes to Valvular Oxidative Stress: A Prospective Observational Pilot Study in Patients with Severe Mitral Regurgitation
Raluca Şoşdean, Maria D. Dănilă, Loredana N. Ionică, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10307-10307
Open Access | Times Cited: 3
The genetic consequences of dog breed formation—Accumulation of deleterious genetic variation and fixation of mutations associated with myxomatous mitral valve disease in cavalier King Charles spaniels
Erik Axelsson, Ingrid Ljungvall, Priyasma Bhoumik, et al.
PLoS Genetics (2021) Vol. 17, Iss. 9, pp. e1009726-e1009726
Open Access | Times Cited: 21
Decreased serotonin transporter activity in the mitral valve contributes to progression of degenerative mitral regurgitation
Estíbaliz Castillero, Emmett Fitzpatrick, Samuel Keeney, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 677
Open Access | Times Cited: 8
Genetics of canine myxomatous mitral valve disease
Mitchell J. O’Brien, Niek Beijerink, Claire M. Wade
Animal Genetics (2021) Vol. 52, Iss. 4, pp. 409-421
Open Access | Times Cited: 17
Cardiovascular serotonergic system: Evolution, receptors, transporter, and function
Gerald Soslau
Journal of Experimental Zoology Part A Ecological and Integrative Physiology (2021) Vol. 337, Iss. 2, pp. 115-127
Closed Access | Times Cited: 17
Serum untargeted metabolomic changes in response to diet intervention in dogs with preclinical myxomatous mitral valve disease
Qinghong Li, Dorothy P. Laflamme, John E. Bauer
PLoS ONE (2020) Vol. 15, Iss. 6, pp. e0234404-e0234404
Open Access | Times Cited: 15
Metabolic Reprogramming, Gut Dysbiosis, and Nutrition Intervention in Canine Heart Disease
Qinghong Li
Frontiers in Veterinary Science (2022) Vol. 9
Open Access | Times Cited: 9
Dynamic changes in mitral valve extracellular matrix, tissue mechanics and function in a mouse model of Marfan syndrome
Brittany A. Gonzalez, Samuel W. Harmeyer, Taejeong Song, et al.
Matrix Biology (2024) Vol. 126, pp. 1-13
Open Access | Times Cited: 1
Challenging the status quo: a framework for mechanistic and human-relevant cardiovascular safety screening
Brian R. Berridge, Jennifer Pierson, Syril Pettit, et al.
Frontiers in Toxicology (2024) Vol. 6
Open Access | Times Cited: 1
Platelet hyperresponsiveness and increased platelet‐neutrophil aggregates in dogs with myxomatous mitral valve disease and pulmonary hypertension
Laetitia Duler, Lance C. Visser, Nghi Nguyen, et al.
Journal of Veterinary Internal Medicine (2024) Vol. 38, Iss. 4, pp. 2052-2063
Open Access | Times Cited: 1
Study of the Arrhythmogenic Profile of Dogs with Myxomatous Mitral Valve Disease in Stages B1 and B2
Beatriz Almeida Santos, Jaqueline Valença Corrêa, Carolina Dragone Latini, et al.
Veterinary Sciences (2024) Vol. 11, Iss. 10, pp. 467-467
Open Access | Times Cited: 1
Pleiotropic Effects of Resveratrol on Aging-Related Cardiovascular Diseases—What Can We Learn from Research in Dogs?
Arkadiusz Grzeczka, Szymon Graczyk, Paweł Kordowitzki
Cells (2024) Vol. 13, Iss. 20, pp. 1732-1732
Open Access | Times Cited: 1
Multimodality imaging and transcriptomics to phenotype mitral valve dystrophy in a unique knock-in Filamin-A rat model
Constance Delwarde, Claire Toquet, Pascal Aumond, et al.
Cardiovascular Research (2022) Vol. 119, Iss. 3, pp. 759-771
Open Access | Times Cited: 7
Asymptomatic Canine Degenerative Valve Disease
Sonya G. Gordon, Ashley B. Saunders, S. Wesselowski
Veterinary Clinics of North America Small Animal Practice (2022) Vol. 52, Iss. 3, pp. 819-840
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top